Immunofluorescence Sample Clauses

Immunofluorescence. For SIRT2 localization experiments, U2OS cells were transfected with SIRT2-FLAG WT or mutants, treated 72 hours post transfection with 5 nM Leptomycin B (Sigma) for 4 hours, fixed in 4% PFA for 10 minutes, and permeabilized in 0.5% triton X-100 for 10 minutes. Cells were blocked in 5% BSA and immunostained with anti-FLAG (Cell Signaling: 2368P) and Alexa Fluor 555 anti-rabbit secondary antibody (Invitrogen) followed by DAPI stain (Southern Biotech). For GFP-ATRIP experiments, a stably transfected GFP-ATRIP U2OS cell line was used. Cells were transfected with nontargeting siRNA (siNS) or siSIRT2-5 followed by transfection with pcDNA3.1 empty vector (EV) or SIRT2-FLAG WT or mutants. SIRT2-FLAG constructs contained wobble mutations to protect exogenous expression from knockdown. Cells were treated with 3mM HU for 24 hours prior to fixation and were fixed and blocked as described above. Cells were immunostained with anti-FLAG (Cell Signaling: 2368P) followed by Alexa Fluor 555 secondary antibody (red), and DAPI Stain. GFP-ATRIP did not require antibody (green). SIRT2-FLAG positive cells were used for quantitation of these experiments with an exception for EV transfected conditions. For spontaneous γH2AX foci experiments, we utilized SIRT2 WT or KO U2OS cells transfected with or without SIRT2-FLAG WT or mutants [95]. Cells were fixed and blocked as described above, immunostained with anti-FLAG (Cell Signaling: 2368P) and anti-γH2AX (Millipore 05- 636) followed by Alexa Fluor 488/555 secondary antibodies and DAPI stain. SIRT2- FLAG positive cells were used for quantitation of these experiments with an exception for non-SIRT2 transfected conditions. Percentage of cells positive for GFP-ATRIP or γH2AX foci was counted from three replicas of 100 cells each. Micronuclei experiments were fixed and processed as described above. Only SIRT2-FLAG positive cells were used in quantitation analysis. The percentage of cells positive for micronuclei was counted from three replicas with 100 cells each. All Images were captured on a Zeiss Observer Z1 microscope equipped with Axio vision Rel 4.8 software. Harvested cells were lysed for 30 minutes on ice in Nonidet P-40 buffer (200 mM NaCl, 1% Nonidet P-40, 50 mM Tris·HCl pH 8.0) freshly supplemented with protease inhibitors. Protein samples were resolved by SDS/PAGE and probed with indicated antibodies: SIRT2 (Santa Xxxx sc-20966), GAPDH (Santa Xxxx sc-25778 or sc-47724), Flag (Sigma F4042), CDK9 (Santa Xxxx sc-13130), GFP (Abca...
Sample 1
AutoNDA by SimpleDocs
Immunofluorescence. Embryos were dissected in phosphate buffer saline (PBS) with 0.4% bovine serum albumin (BSA), and fixed in 4% paraformaldehyde (PFA) at 4°C for 1 hour. The fix was removed by washing in PBS at 4°C for 2 hours before being placed in 30% sucrose at 4°C overnight. Embryos were washed in OCT at least twice prior to being embedded in OCT. Frozen embryos were sectioned at 10-μm thickness. Slides were washed in antibody solution (10% heat-inactivated goat serum and 0.1% Triton X-100 in PBS) at RT for 10 minutes, and incubated with primary antibodies at 4°C overnight. After washing several times in antibody solution at RT, slides were incubated with secondary antibodies for 1 hour at RT in dark. Slides were washed, and mounted with prolong antifade mounting solution. Primary antibodies used were rabbit anti-Arl13b (serum 503, 1:1500), mouse anti-Cre (Sigma C7988, 1:500), rabbit anti-Olig2 (Millipore AB9610, 1:300), PDGFRα (GeneTex 558774, 1:100), and rabbit anti-Smoothened (Dr. Xxxxxxx Xxxxxxxx, 1:500). Mouse anti-FoxA2, HB9, Nkx2.2, Nkx6.1, Pax6, and Shh primary antibodies were obtained from Developmental Studies Hybridoma Bank, and the 1:10 dilution was used. Secondary antibodies were obtained from Invitrogen for AlexFlour series of anti-rabbit (A11034 for 488nm; A11011 for 568 nm), anti-mouse (A11029 for 488nm; A11031 for 568 nm), and anti-rat (A21471 for 594 nm). The dilution for secondary antibodies was 1:200. For staining mouse embryonic fibroblasts, cells were washed with PBS and fixed in 4% PFA for 10 minutes and then stained as described for embryonic frozen sections. For whole mount staining, E8.5 embryos were fixed in 2% PFA for 20 minutes at RT and washed with PBS for 10 minutes. Embryos were then permeabilized in PBS with 0.1% Triton X-100 and 100mM glycine for 10 minutes, and washed in PBS for 10 minutes. After blocking in blocking buffer (10% calf serum, 0.1% BSA, and 1.5% heat- inactivated sheep serum (HISS) in TBST containing 20mM Tris, 150mM NaCl, 0.05%Tween-20) at RT for 3 hours, embryos were incubated with primary antibody in TBST with 0.1% BSA and 1.5% HISS at 4°C overnight. The next day, embryos were washed in TBST and then incubated with secondary antibody in TBST at RT for 3 hours in dark. Embryos were washed in TBST several times and taken pictures by Leica MZFLIII stereomicroscope.
Sample 1
Immunofluorescence. All immunofluorescent staining experiments were performed on cells seeded at appropriate density on fibronectin coated coverslips. On the day of immunofluorescent labelling, cells were washed 3 times with PBS and fixed with 4% PFA for 20 min. Following another 3 PBS washes, cells were permeabilised with 0.2% X-triton to break the cell membranes for 5 minutes. Following another 3 washes, coverslips were blocked with 5% FBS for 30 min and 3% BSA:PBS for another 30 min. Cells were then incubated with the primary antibody appropriately diluted in 3% BSA:PBS for 2 hours in the dark (table 2-3). Once again, cells were washed 3 times with PBS. Secondary antibodies along with Phalloidin and DAPI were diluted appropriately in 3% BSA:PBS. Cells were then incubated with the prepared mixture for 1h in the dark (table 2-4). Coverslips were then washed twice in PBS and once in ddH2O before being mounted on glass slides with the Fluorsave reagent. Coverslips were left in room temperature overnight and then stored at 4°C in the dark. Cells were imaged on an Olympus IX71 microscope using Image ProPlus AMS software.
Sample 1
Immunofluorescence. Wildtype or SIRT2 knockout U2OS cells were transfected with SIRT2-FLAG or SIRT2- FLAG-H187Y expression vectors, or were non-transfected. After 72 h to allow for protein expression, cells were exposed to 0 or 10Gy IR followed by 30 min, 60 min, or 90 min recovery time. Cells were fixed on coverslips with 4% PFA for 10 min, and permeabilized in 0.5% triton X-100 for 10 min. For non-rescue experiments, cells were blocked in 5% BSA and immunostained with anti-γH2AX (Millipore 05-636) and DNA- PKcs phosphoserine 2056 (Abcam, ab18192) followed by Alexa Fluor 555/488 secondary antibodies and DAPI. For rescue experiments, cells were blocked in 5% BSA and immunostained stained with anti-FLAG (Cell Signaling: 2368P) and DNA-PKcs phosphoserine 2056 (Abcam, ab18192) followed by Alexa Fluor 555/488 secondary antibodies and DAPI stain (Southern Biotech). The percentage of cells positive for DNA- PKcs phosphoserine 2056 foci (5 or more foci per nucleus) was counted from 3 biological replicates (100 cells per replica) for each condition.
Sample 1

Related to Immunofluorescence

  • Probes Network hosts used to perform (DNS, EPP, etc.) tests (see below) that are located at various global locations.

  • Preceptor A per diem Registered Nurse 2 may serve as a preceptor after successfully completing a preceptor workshop or equivalent documented training and agreeing to and being appointed to be specifically responsible for planning, organizing, and evaluating the new skill development of one or more RNs as appropriate enrolled in a defined orientation program, the parameters of which have been set forth in writing by the Employer. This includes teaching, clinical supervision, role modeling, feedback, evaluation (verbal and written) and follow up of the new or transferring employee. The per diem RN 2 preceptor is eligible to receive preceptor premium pay when actually engaged in preceptor role responsibilities with/on behalf of the orienting RN. A per diem RN 2 substituting for the original preceptor during a period of absence and who has been designated to carry out the preceptor's complete responsibility (including following and/or adjusting the plan to meet learning needs and providing oral and written evaluation input) will receive preceptor pay. A preceptor may be assigned to a student when it is determined by the Employer that the employee has completed the required preceptor training or has agreed to and been appointed a preceptor. The employee is specifically responsible for planning, organizing, and evaluating the new skill development of the student as appropriately enrolled in a defined program, the parameters of which have been set forth in writing by the Employer. This includes teaching, clinical supervision, role modeling, feedback, evaluation (verbal and written) and follow up of the student.

  • Smoke Detectors At Owner's expense, smoke detectors will be installed on the Property in working condition in accordance with the law prior to the tenant's occupancy. During the occupancy, it shall be the tenant's responsibility to maintain all smoke detectors. Owner will replace smoke detector equipment as needed.

  • Generators Temporary installation of generators, and permanent installation of generators that are placed inside existing buildings or that occupy an area under 50 square feet behind the building they serve.

  • Library Borrowing privileges available without charge. Upon retirement an employee shall be issued a permanent individual library card.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Tolerance Average net mass of cement packed in bags in a sample shall be equal to or more than 50kg. If and as desired by the Engineer-in-Charge, the number of samples to be checked for net mass of cement per bag, in a given number of bags shall be as given below: 100 to 150 bags : 20 sample 150 to 280 bags : 32 sample 281 to 500 bags : 50 sample 501 to 1200 bags : 80 sample 1201 to 3200 bags : 125 sample 3201 and above : 200 sample The bags in a sample shall be selected at random.

  • Preventive Drugs When purchased at any pharmacy: Must be prescribed by a physician. See Prescription Drug section for details. $0 Not Covered Nicotine Replacement Therapy (NRT) and Smoking Cessation Prescription Drugs When purchased at any pharmacy: Must be prescribed by a physician. See Prescription Drug section for details. Tier 1 Preventive: $0 Tier 1 Non-preventive: $10 - After deductible Not Covered Tier 2 Preventive: $0 Tier 2 Non-preventive: $45 - After deductible Not Covered Tier 3: $70 - After deductible Not Covered Tier 4: $90 - After deductible Not Covered Tier 5: NRT and Smoking Cessation drugs are only placed in Tier 1, Tier 2, Tier 3, or Tier 4. See above. Not Covered When purchased at a Mail Order Pharmacy: Not Covered Not Covered

  • Illumination Normal & emergency AC & DC illumination shall be provided adequately in the control room & other buildings of the substation. The switchyard shall also be provided with adequate illumination. Lighting of the entire control room building, fire-fighting pump house, other building (if any) and switchyard shall be done by LED based low power consumption luminaires.

  • Laboratory a. Drug tests shall be conducted by laboratories licensed and approved by SAMSHA which comply with the American Occupational Medical Association (AOMA) ethical standards. Upon advance notice, the parties retain the right to inspect the laboratory to determine conformity with the standards described in this policy. The laboratory will only test for drugs identified in this policy. The City shall bear the cost of all required testing unless otherwise specified herein. b. Tests for all controlled substances, except alcohol, shall be by oral fluid testing and shall consist of two procedures, a screen test and, if that is positive, a confirmation test. c. To be considered positive for reporting by the laboratory to the City, both samples must be tested separately in separate batches and must also show positive results on the confirmatory test. d. In the event of a positive test, the testing laboratory will perform an automatic confirmation test on the original specimen at no cost to the Covered Employee. In addition, the testing laboratory shall preserve a sufficient specimen to permit an independent re-testing at the Covered Employee’s request and expense. The same, or any other, approved laboratory may conduct re-tests. The laboratory shall endeavor to notify the designated MRO of positive drug, alcohol, or adulterant tests results within five (5) working days after receipt of the specimen.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!